There is extensive literature examining the concordance between paired core biopsy and excisional samples underlying the recommendations of breast cancer clinical guidelines to use core biopsies for routine assessment of ER, PR, and HER2 receptor status, tumor grade, and histologic subtype.5, 6, 7, 8. The gene discussed is PGR; the disease is breast cancer.